treatment of mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS)
All entries for: Kalevala Therapeutics, Inc.
September 30, 2026
Kalevala Therapeutics, Inc.
Orphan Drug Designation
Dover. DE
1-50 employees
Disease Area: Rare Disease
September 25, 2026
Kalevala Therapeutics, Inc.
Orphan Drug Designation
Dover. DE
1-50 employees
Disease Area: Rare Disease
September 22, 2026
Kalevala Therapeutics, Inc.
Orphan Drug Designation
Dover. DE
1-50 employees
Disease Area: Rare Disease
August 27, 2026
Kalevala Therapeutics, Inc.
Orphan Drug Designation
Dover. DE
1-50 employees
Disease Area: Rare Disease